英国金士顿大学论文代写 ：欧洲兽医管理
欧洲的兽医管理属于欧洲药物管理局或EMA (EMA, 2015)的监管监督。EMA与欧洲药物和药物成瘾监测中心(European Monitoring Centre for Drugs and Drug Addiction)一起，EMCDDA负责动物精神药物治疗的风险评估、信息交流和管理所需的信息。为此，欧盟的授权如下:规例(欧盟)第1235/2010号。这是一项直接隶属于欧洲议会修改2004年制定的法规的章节的规定。这些授权的目的是确保兽药即使在人食用后也不会继续保持其精神活性状态。因此，“兽药的初始批准、在农场的使用以及动物或其食品在经过特定治疗后多久可用于人类消费”受本法管辖(环境食品和农村事务部，2012年)。这项立法的目的是保护消费者，阻止兽医药物残留进入食物链，达到不可接受的水平或浓度。
英国金士顿大学论文代写 ：欧洲兽医管理
最大残留限量(MRLs)和停药期是实现这一目标的一部分。所述的主要内容将包括将使用的MRL的形式，当使用某种兽药时，注射了该药的牲畜在退出前可用于肉类工业和其他行业的时间。有时甚至在退出期之后，对家畜可能需要某种形式的监视和长期检查(Seri, 2013)。在过去，当涉及残留水平时，处于问题区域的牲畜尤其如此。欧洲管理当局规定，必须将剩余的监测记录维持一段特定时期。记录维护得越好，与剩余级别和监视相关的风险就越少。每个农场的管理人员都必须提供关于农场使用的兽药产品的识别信息、提供的任何形式的兽药、对兽药的任何不良反应记录等信息(EMA, 2015)。
英国金士顿大学论文代写 ：欧洲兽医管理
Veterinary medicine management in the Europe falls under the regulatory supervision of European Medicines Agency or the EMA (EMA, 2015). The EMA along with the European Monitoring Centre for Drugs and Drug Addiction, the EMCDDA deals with the information necessary for the risks assessments, information exchange and control of administration of psychoactive veterinary medications in animals. The mandates under the EU followed for this are the Regulation (EU) No 1235/2010. This is a regulation that comes directly under the sections of the European Parliament amending regulations laid down in the year 2004. The purpose of these authorizations are to ensure that the veterinary drug medicines does not persist in its psychoactive state even after human consumption. “The initial authorization of a veterinary medicine, its use on farms and how long after any particular treatment an animal or its food products may be used for human consumption” is hence covered by this law (Department of Environmental Food and Rural Affairs, 2012). The legislation aims to protect consumers by stopping unacceptable levels or concentrations of residues from veterinary medicines getting into the food chain.
英国金士顿大学论文代写 ：欧洲兽医管理
Maximum Residue Limits (MRLs) and withdrawal periods are set as part of achieving this objective. The major elements as addressed will include the form of MRL to be used, when a certain veterinary medicine is used what would be the withdrawal period before which the livestock which has been injected with the drug can be made available for the meat industry and more. Sometimes even after a withdrawal period some form of surveillance and long term inspection might be necessary with livestock (Seri, 2013). This is especially the case of livestock that has fallen under the problem zone when it comes to residual levels in the past. The European management dictates that it would be necessary for the residual level monitoring records to be maintained for some specific time period. The better the records maintained are, the lesser the amount of risks that are associated with the residual level and monitoring. Every farm management will have to provide the information on the identification of veterinary medical products that are used in the farm, any form of veterinary medicine that was given, any recording of adverse reaction to the veterinary medicine and more (EMA, 2015).